Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone binding of Zometa in patients with myeloma or breast cancer with bone metastases
2007-003777-13Phase 2Completed
- Sponsor
- Vejle Hospital
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of zoledronic acid in multiple myeloma (MM) and breast cancer (2 arms), sponsored by Vejle Hospital. Started Aug 2007; status: completed.
02
Drugs
zoledronic acid
03
Conditions
multiple myeloma (MM)breast cancer
Beyond the preview
Go deeper on 2007-003777-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003777-13.